Cedar Hill Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $338K | Sell |
8,170
-8,453
| -51% | -$350K | 0.13% | 84 |
|
|
2018
Q3 | $695K | Sell |
16,623
-14,912
| -47% | -$623K | 0.16% | 77 |
|
|
2018
Q2 | $1.09M | Sell |
31,535
-2,606
| -8% | -$89.7K | 0.23% | 74 |
|
|
2018
Q1 | $1.15M | Sell |
34,141
-127
| -0.4% | -$4.28K | 0.23% | 73 |
|
|
2017
Q4 | $1.18M | Sell |
34,268
-281
| -0.8% | -$9.65K | 0.2% | 74 |
|
|
2017
Q3 | $1.17M | Buy |
34,549
+22,760
| +193% | +$771K | 0.2% | 73 |
|
|
2017
Q2 | $376K | Sell |
11,789
-1,603
| -12% | -$51.1K | 0.08% | 68 |
|
|
2017
Q1 | $435K | Hold |
13,392
| – | – | 0.09% | 66 |
|
|
2016
Q4 | $413K | Buy |
13,392
+336
| +3% | +$10.4K | 0.07% | 66 |
|
|
2016
Q3 | $420K | Sell |
13,056
-632
| -5% | -$20.3K | 0.07% | 65 |
|
|
2016
Q2 | $457K | Sell |
13,688
-163
| -1% | -$5.44K | 0.08% | 64 |
|
|
2016
Q1 | $389K | Hold |
13,851
| – | – | 0.07% | 67 |
|
|
2015
Q4 | $424K | Sell |
13,851
-35
| -0.3% | -$1.07K | 0.07% | 67 |
|
|
2015
Q3 | $414K | Buy |
13,886
+198
| +1% | +$5.9K | 0.07% | 67 |
|
|
2015
Q2 | $435K | Sell |
13,688
-693
| -5% | -$22K | 0.07% | 68 |
|
|
2015
Q1 | $475K | Sell |
14,381
-193
| -1% | -$6.38K | 0.08% | 68 |
|
|
2014
Q4 | $431K | Sell |
14,574
-316
| -2% | -$9.35K | 0.07% | 72 |
|
|
2014
Q3 | $418K | Sell |
14,890
-716
| -5% | -$20.1K | 0.07% | 71 |
|
|
2014
Q2 | $439K | Buy |
15,606
+1,344
| +9% | +$37.8K | 0.07% | 68 |
|
|
2014
Q1 | $435K | Sell |
14,262
-580
| -4% | -$17.7K | 0.07% | 66 |
|
|
2013
Q4 | $431K | Hold |
14,842
| – | – | 0.08% | 67 |
|
|
2013
Q3 | $405K | Sell |
14,842
-858
| -5% | -$23.4K | 0.08% | 65 |
|
|
2013
Q2 | $417K | Buy |
+15,700
| New | +$417K | 0.08% | 68 |
|